Company intelligence / Profile preview

Antera Therapeutics

Cambridge/Boston, Massachusetts, United Statesprnewswire.com ↗

Ownership: Private
Employees: ~5
Development stage: Preclinical

Overview

Developed an all-natural regimen to reduce the risk of allergy development in infants, with initial focus on peanut allergies. Was set to launch with over 100 clinics in the US, including partnerships with Tufts Medical Center, Boston Children's, MGH, and Stanford[3].

Therapeutic areas: Immunology
Modalities: All-natural products/therapies
Industry: Biotech

Drug pipeline

1 asset

F P+P -L6 1+3

Pre-clinical

Indications: Osteoporosis, Bone fracture, Short bowel syndrome, Mucositis

Partnerships

Tufts Medical CenterBoston Children's HospitalMassachusetts General Hospital (MGH)Stanford[3]

Beyond the preview

Go deeper on Antera Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antera Therapeutics.

Explore the full profile